News
Roche Warns of Counterfeit Avastin in the U S
The maker of the widely prescribed cancer drug Avastin is warning doctors and patients about counterfeit vials of the product that have been
Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020 | PRLog
Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020. The Global Type 2 Diabetes Therapeutics Market was worth $23.7 Billion in 2011, Driven by the Growth in the Patient Volume and Annual Cost of Type 2 Diabetes Therapy - PR11799503
Progenics Should Outperform The Market In The Short Term - Seeking Alpha
< strong > By < a href='http://binaryleverage.com/' > Niall Corrigan < /a > : < /strong > < p > < strong > Overview < /strong > < br/ > By a strange coincidence, I am currently long both Progenics Pharmaceuticals Inc. ( < a href='http://seekingalpha.com/symbol/pgnx' title='Progenics Pharmaceuticals
amednews: Defensive medicine seeping into physician training, study says :: Feb. 15, 2012 ...
Most students and residents at one medical school witness the practice in clinical training. They are taught to factor medical liability into patient-care decisions.
Roche warns of fake cancer drug in US - FT.com
Roche, the Swiss drugmaker, warned that counterfeit versions of Avastin, its top-selling cancer drug, were being circulated in the US, potentially putting patients at risk. “The counterfeit product is not safe or effective and should not be used,”
Hearing Aid Gap: Millions Who Could Benefit Remain UNtreated - 02/13/2012
Though an estimated 26.7 million Americans age 50 and older have hearing loss, only about one in seven uses a hearing aid, according to a new study led by Johns Hopkins researchers.
ICON, Empire Genomi | ICON, Empire Genomics enters into partnership | PharmaAsia
ICON and Empire Genomics will partner to develop a service portfolio tailored to the development of personalised medicines. The partnership combines Empire Genomics’ expertise in pharmacogenomics, computational modeling of disease state, drug disposition and drug targets with ICON’s expertise in
Frost & Sullivan Launches the U.S. Drug Delivery: Voice of the Customer 2012 Feasibility Survey |
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.
Process Analytical Technology | Watson Commits to PAT and QbD for Generic Drug Development |
Watson Pharmaceuticals, Inc. announced plans to establish a Global R&D Technology Center in North Brunswick, New Jersey. The Company has signed a lease for a 32,000-square-foot facility at the New Jersey Economic Development Authority's Technology Centre of New Jersey, a 50-acre complex consisting
Merck News Item
Merck & Co., Inc. home investors newsroom licensing careers contact us United States Canada MSD Worldwide About Us Our Values Be well Leadership How We Operate Views and Positions Our History Featured Stories Corporate Responsibility Research Pipeline Discovery & Development Products Vaccines
Refine by Content Type:
Refine by Source:
- www.australiandoctor.com.au (19,485)
- www.medpagetoday.com (5,526)
- www.prlog.org (4,889)
- www.thelancet.com (4,410)
- www.webmd.com (2,855)
- www.dddmag.com (2,855)
- www.genengnews.com (2,246)
- diabetes.webmd.com (1,772)
- imt.ie (1,663)
- pharmtech.findpharma.com (1,422)
- www.biospace.com (1,313)
- download.thelancet.com (1,238)
